nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Toremifene—ESR1—osteoporosis	0.00297	0.274	CrCbGaD
Doxylamine—Levomethadyl Acetate—CYP19A1—osteoporosis	0.00218	0.201	CrCbGaD
Doxylamine—Tamoxifen—ESR2—osteoporosis	0.00192	0.178	CrCbGaD
Doxylamine—Constipation—Estropipate—osteoporosis	0.00181	0.00183	CcSEcCtD
Doxylamine—Ill-defined disorder—Pamidronate—osteoporosis	0.0018	0.00182	CcSEcCtD
Doxylamine—Hypersensitivity—Etidronic acid—osteoporosis	0.0018	0.00182	CcSEcCtD
Doxylamine—Insomnia—Calcitriol—osteoporosis	0.00179	0.00181	CcSEcCtD
Doxylamine—Agitation—Pamidronate—osteoporosis	0.00179	0.00181	CcSEcCtD
Doxylamine—Anxiety—Ethinyl Estradiol—osteoporosis	0.00178	0.0018	CcSEcCtD
Doxylamine—Constipation—Alendronate—osteoporosis	0.00178	0.0018	CcSEcCtD
Doxylamine—Angioedema—Pamidronate—osteoporosis	0.00178	0.0018	CcSEcCtD
Doxylamine—Erythema—Zoledronate—osteoporosis	0.00178	0.00179	CcSEcCtD
Doxylamine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00177	0.00179	CcSEcCtD
Doxylamine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00177	0.00179	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00177	0.00178	CcSEcCtD
Doxylamine—Discomfort—Ethinyl Estradiol—osteoporosis	0.00176	0.00178	CcSEcCtD
Doxylamine—Somnolence—Calcitriol—osteoporosis	0.00176	0.00178	CcSEcCtD
Doxylamine—Decreased appetite—Ibandronate—osteoporosis	0.00176	0.00178	CcSEcCtD
Doxylamine—Malaise—Pamidronate—osteoporosis	0.00175	0.00177	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00175	0.00177	CcSEcCtD
Doxylamine—Depression—Estradiol—osteoporosis	0.00175	0.00176	CcSEcCtD
Doxylamine—Fatigue—Ibandronate—osteoporosis	0.00175	0.00176	CcSEcCtD
Doxylamine—Leukopenia—Pamidronate—osteoporosis	0.00174	0.00176	CcSEcCtD
Doxylamine—Anxiety—Risedronate—osteoporosis	0.00173	0.00175	CcSEcCtD
Doxylamine—Constipation—Ibandronate—osteoporosis	0.00173	0.00175	CcSEcCtD
Doxylamine—Pruritus—Etidronic acid—osteoporosis	0.00173	0.00175	CcSEcCtD
Doxylamine—Decreased appetite—Calcitriol—osteoporosis	0.00172	0.00174	CcSEcCtD
Doxylamine—Feeling abnormal—Alendronate—osteoporosis	0.00171	0.00173	CcSEcCtD
Doxylamine—Erythema—Conjugated Estrogens—osteoporosis	0.00171	0.00173	CcSEcCtD
Doxylamine—Muscle spasms—Zoledronate—osteoporosis	0.00171	0.00173	CcSEcCtD
Doxylamine—Dry mouth—Risedronate—osteoporosis	0.0017	0.00172	CcSEcCtD
Doxylamine—Constipation—Calcitriol—osteoporosis	0.00169	0.00171	CcSEcCtD
Doxylamine—Convulsion—Pamidronate—osteoporosis	0.00168	0.0017	CcSEcCtD
Doxylamine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00168	0.0017	CcSEcCtD
Doxylamine—Urticaria—Estropipate—osteoporosis	0.00168	0.0017	CcSEcCtD
Doxylamine—Diarrhoea—Etidronic acid—osteoporosis	0.00167	0.00169	CcSEcCtD
Doxylamine—Feeling abnormal—Ibandronate—osteoporosis	0.00167	0.00169	CcSEcCtD
Doxylamine—Tremor—Zoledronate—osteoporosis	0.00166	0.00168	CcSEcCtD
Doxylamine—Urticaria—Alendronate—osteoporosis	0.00165	0.00167	CcSEcCtD
Doxylamine—Anxiety—Pamidronate—osteoporosis	0.00165	0.00167	CcSEcCtD
Doxylamine—Ill-defined disorder—Zoledronate—osteoporosis	0.00165	0.00167	CcSEcCtD
Doxylamine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00164	0.00166	CcSEcCtD
Doxylamine—Nervous system disorder—Risedronate—osteoporosis	0.00164	0.00165	CcSEcCtD
Doxylamine—Discomfort—Pamidronate—osteoporosis	0.00163	0.00165	CcSEcCtD
Doxylamine—Agitation—Zoledronate—osteoporosis	0.00163	0.00165	CcSEcCtD
Doxylamine—Angioedema—Zoledronate—osteoporosis	0.00162	0.00164	CcSEcCtD
Doxylamine—Urticaria—Ibandronate—osteoporosis	0.00161	0.00163	CcSEcCtD
Doxylamine—Malaise—Zoledronate—osteoporosis	0.0016	0.00162	CcSEcCtD
Doxylamine—Confusional state—Pamidronate—osteoporosis	0.0016	0.00162	CcSEcCtD
Doxylamine—Vertigo—Zoledronate—osteoporosis	0.00159	0.00161	CcSEcCtD
Doxylamine—Leukopenia—Zoledronate—osteoporosis	0.00159	0.00161	CcSEcCtD
Doxylamine—Anaphylactic shock—Pamidronate—osteoporosis	0.00159	0.0016	CcSEcCtD
Doxylamine—Urticaria—Calcitriol—osteoporosis	0.00157	0.00159	CcSEcCtD
Doxylamine—Hepatitis—Estradiol—osteoporosis	0.00157	0.00159	CcSEcCtD
Doxylamine—Palpitations—Zoledronate—osteoporosis	0.00157	0.00159	CcSEcCtD
Doxylamine—Angioedema—Conjugated Estrogens—osteoporosis	0.00156	0.00158	CcSEcCtD
Doxylamine—Hypersensitivity—Estropipate—osteoporosis	0.00156	0.00157	CcSEcCtD
Doxylamine—Nervous system disorder—Pamidronate—osteoporosis	0.00156	0.00157	CcSEcCtD
Doxylamine—Thrombocytopenia—Pamidronate—osteoporosis	0.00155	0.00157	CcSEcCtD
Doxylamine—Urinary tract disorder—Estradiol—osteoporosis	0.00155	0.00157	CcSEcCtD
Doxylamine—Vomiting—Etidronic acid—osteoporosis	0.00155	0.00157	CcSEcCtD
Doxylamine—Tachycardia—Pamidronate—osteoporosis	0.00155	0.00156	CcSEcCtD
Doxylamine—Urethral disorder—Estradiol—osteoporosis	0.00154	0.00156	CcSEcCtD
Doxylamine—Rash—Etidronic acid—osteoporosis	0.00154	0.00156	CcSEcCtD
Doxylamine—Convulsion—Zoledronate—osteoporosis	0.00154	0.00155	CcSEcCtD
Doxylamine—Dermatitis—Etidronic acid—osteoporosis	0.00154	0.00155	CcSEcCtD
Doxylamine—Vertigo—Conjugated Estrogens—osteoporosis	0.00154	0.00155	CcSEcCtD
Doxylamine—Hyperhidrosis—Pamidronate—osteoporosis	0.00153	0.00155	CcSEcCtD
Doxylamine—Hypersensitivity—Alendronate—osteoporosis	0.00153	0.00155	CcSEcCtD
Doxylamine—Asthenia—Estropipate—osteoporosis	0.00151	0.00153	CcSEcCtD
Doxylamine—Anorexia—Pamidronate—osteoporosis	0.00151	0.00153	CcSEcCtD
Doxylamine—Palpitations—Conjugated Estrogens—osteoporosis	0.00151	0.00153	CcSEcCtD
Doxylamine—Insomnia—Risedronate—osteoporosis	0.00151	0.00153	CcSEcCtD
Doxylamine—Anxiety—Zoledronate—osteoporosis	0.00151	0.00152	CcSEcCtD
Doxylamine—Pruritus—Estropipate—osteoporosis	0.00149	0.00151	CcSEcCtD
Doxylamine—Discomfort—Zoledronate—osteoporosis	0.00149	0.00151	CcSEcCtD
Doxylamine—Asthenia—Alendronate—osteoporosis	0.00149	0.00151	CcSEcCtD
Doxylamine—Hypersensitivity—Ibandronate—osteoporosis	0.00149	0.00151	CcSEcCtD
Doxylamine—Dyspnoea—Risedronate—osteoporosis	0.00149	0.0015	CcSEcCtD
Doxylamine—Erythema multiforme—Estradiol—osteoporosis	0.00149	0.0015	CcSEcCtD
Doxylamine—Hypotension—Pamidronate—osteoporosis	0.00148	0.0015	CcSEcCtD
Doxylamine—Convulsion—Conjugated Estrogens—osteoporosis	0.00148	0.0015	CcSEcCtD
Doxylamine—Dry mouth—Zoledronate—osteoporosis	0.00148	0.00149	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00148	0.00149	CcSEcCtD
Doxylamine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00148	0.00149	CcSEcCtD
Doxylamine—Pruritus—Alendronate—osteoporosis	0.00147	0.00149	CcSEcCtD
Doxylamine—Eye disorder—Estradiol—osteoporosis	0.00147	0.00148	CcSEcCtD
Doxylamine—Constipation—Ethinyl Estradiol—osteoporosis	0.00146	0.00148	CcSEcCtD
Doxylamine—Confusional state—Zoledronate—osteoporosis	0.00146	0.00148	CcSEcCtD
Doxylamine—Hypersensitivity—Calcitriol—osteoporosis	0.00146	0.00148	CcSEcCtD
Doxylamine—Flushing—Estradiol—osteoporosis	0.00146	0.00147	CcSEcCtD
Doxylamine—Cardiac disorder—Estradiol—osteoporosis	0.00146	0.00147	CcSEcCtD
Doxylamine—Asthenia—Ibandronate—osteoporosis	0.00145	0.00147	CcSEcCtD
Doxylamine—Anxiety—Conjugated Estrogens—osteoporosis	0.00145	0.00147	CcSEcCtD
Doxylamine—Nausea—Etidronic acid—osteoporosis	0.00145	0.00147	CcSEcCtD
Doxylamine—Anaphylactic shock—Zoledronate—osteoporosis	0.00145	0.00146	CcSEcCtD
Doxylamine—Diarrhoea—Estropipate—osteoporosis	0.00144	0.00146	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00144	0.00146	CcSEcCtD
Doxylamine—Fatigue—Risedronate—osteoporosis	0.00144	0.00145	CcSEcCtD
Doxylamine—Insomnia—Pamidronate—osteoporosis	0.00143	0.00145	CcSEcCtD
Doxylamine—Pruritus—Ibandronate—osteoporosis	0.00143	0.00145	CcSEcCtD
Doxylamine—Constipation—Risedronate—osteoporosis	0.00143	0.00144	CcSEcCtD
Doxylamine—Diarrhoea—Alendronate—osteoporosis	0.00142	0.00144	CcSEcCtD
Doxylamine—Asthenia—Calcitriol—osteoporosis	0.00142	0.00144	CcSEcCtD
Doxylamine—Nervous system disorder—Zoledronate—osteoporosis	0.00142	0.00144	CcSEcCtD
Doxylamine—Immune system disorder—Estradiol—osteoporosis	0.00142	0.00143	CcSEcCtD
Doxylamine—Thrombocytopenia—Zoledronate—osteoporosis	0.00142	0.00143	CcSEcCtD
Doxylamine—Mediastinal disorder—Estradiol—osteoporosis	0.00142	0.00143	CcSEcCtD
Doxylamine—Dyspnoea—Pamidronate—osteoporosis	0.00141	0.00143	CcSEcCtD
Doxylamine—Tachycardia—Zoledronate—osteoporosis	0.00141	0.00143	CcSEcCtD
Doxylamine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00141	0.00143	CcSEcCtD
Doxylamine—Somnolence—Pamidronate—osteoporosis	0.00141	0.00143	CcSEcCtD
Doxylamine—Pruritus—Calcitriol—osteoporosis	0.0014	0.00142	CcSEcCtD
Doxylamine—Hyperhidrosis—Zoledronate—osteoporosis	0.0014	0.00142	CcSEcCtD
Doxylamine—Diarrhoea—Raloxifene—osteoporosis	0.0014	0.00141	CcSEcCtD
Doxylamine—Dizziness—Estropipate—osteoporosis	0.0014	0.00141	CcSEcCtD
Doxylamine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00139	0.00141	CcSEcCtD
Doxylamine—Diarrhoea—Ibandronate—osteoporosis	0.00139	0.0014	CcSEcCtD
Doxylamine—Anorexia—Zoledronate—osteoporosis	0.00138	0.0014	CcSEcCtD
Doxylamine—Decreased appetite—Pamidronate—osteoporosis	0.00138	0.00139	CcSEcCtD
Doxylamine—Dizziness—Alendronate—osteoporosis	0.00138	0.00139	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00137	0.00138	CcSEcCtD
Doxylamine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00137	0.00138	CcSEcCtD
Doxylamine—Erythema—Estradiol—osteoporosis	0.00137	0.00138	CcSEcCtD
Doxylamine—Fatigue—Pamidronate—osteoporosis	0.00137	0.00138	CcSEcCtD
Doxylamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00136	0.00138	CcSEcCtD
Doxylamine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00136	0.00137	CcSEcCtD
Doxylamine—Constipation—Pamidronate—osteoporosis	0.00136	0.00137	CcSEcCtD
Doxylamine—Diarrhoea—Calcitriol—osteoporosis	0.00136	0.00137	CcSEcCtD
Doxylamine—Hypotension—Zoledronate—osteoporosis	0.00135	0.00137	CcSEcCtD
Doxylamine—Dizziness—Raloxifene—osteoporosis	0.00135	0.00137	CcSEcCtD
Doxylamine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00135	0.00136	CcSEcCtD
Doxylamine—Vomiting—Estropipate—osteoporosis	0.00134	0.00136	CcSEcCtD
Doxylamine—Dizziness—Ibandronate—osteoporosis	0.00134	0.00135	CcSEcCtD
Doxylamine—Rash—Estropipate—osteoporosis	0.00133	0.00135	CcSEcCtD
Doxylamine—Dermatitis—Estropipate—osteoporosis	0.00133	0.00134	CcSEcCtD
Doxylamine—Anorexia—Conjugated Estrogens—osteoporosis	0.00133	0.00134	CcSEcCtD
Doxylamine—Urticaria—Risedronate—osteoporosis	0.00133	0.00134	CcSEcCtD
Doxylamine—Vomiting—Alendronate—osteoporosis	0.00132	0.00134	CcSEcCtD
Doxylamine—Muscle spasms—Estradiol—osteoporosis	0.00132	0.00133	CcSEcCtD
Doxylamine—Rash—Alendronate—osteoporosis	0.00131	0.00133	CcSEcCtD
Doxylamine—Insomnia—Zoledronate—osteoporosis	0.00131	0.00132	CcSEcCtD
Doxylamine—Dermatitis—Alendronate—osteoporosis	0.00131	0.00132	CcSEcCtD
Doxylamine—Feeling abnormal—Pamidronate—osteoporosis	0.00131	0.00132	CcSEcCtD
Doxylamine—Hypotension—Conjugated Estrogens—osteoporosis	0.0013	0.00132	CcSEcCtD
Doxylamine—Vomiting—Raloxifene—osteoporosis	0.0013	0.00131	CcSEcCtD
Doxylamine—Dyspnoea—Zoledronate—osteoporosis	0.00129	0.00131	CcSEcCtD
Doxylamine—Rash—Raloxifene—osteoporosis	0.00129	0.0013	CcSEcCtD
Doxylamine—Dermatitis—Raloxifene—osteoporosis	0.00129	0.0013	CcSEcCtD
Doxylamine—Somnolence—Zoledronate—osteoporosis	0.00129	0.0013	CcSEcCtD
Doxylamine—Vomiting—Ibandronate—osteoporosis	0.00129	0.0013	CcSEcCtD
Doxylamine—Tamoxifen—CYP19A1—osteoporosis	0.00129	0.119	CrCbGaD
Doxylamine—Tremor—Estradiol—osteoporosis	0.00128	0.0013	CcSEcCtD
Doxylamine—Rash—Ibandronate—osteoporosis	0.00128	0.00129	CcSEcCtD
Doxylamine—Methadone—CYP19A1—osteoporosis	0.00128	0.118	CrCbGaD
Doxylamine—Dermatitis—Ibandronate—osteoporosis	0.00128	0.00129	CcSEcCtD
Doxylamine—Ill-defined disorder—Estradiol—osteoporosis	0.00127	0.00128	CcSEcCtD
Doxylamine—Insomnia—Conjugated Estrogens—osteoporosis	0.00126	0.00128	CcSEcCtD
Doxylamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00126	0.00127	CcSEcCtD
Doxylamine—Vomiting—Calcitriol—osteoporosis	0.00126	0.00127	CcSEcCtD
Doxylamine—Decreased appetite—Zoledronate—osteoporosis	0.00126	0.00127	CcSEcCtD
Doxylamine—Agitation—Estradiol—osteoporosis	0.00126	0.00127	CcSEcCtD
Doxylamine—Nausea—Estropipate—osteoporosis	0.00125	0.00127	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00125	0.00126	CcSEcCtD
Doxylamine—Angioedema—Estradiol—osteoporosis	0.00125	0.00126	CcSEcCtD
Doxylamine—Rash—Calcitriol—osteoporosis	0.00125	0.00126	CcSEcCtD
Doxylamine—Fatigue—Zoledronate—osteoporosis	0.00125	0.00126	CcSEcCtD
Doxylamine—Dermatitis—Calcitriol—osteoporosis	0.00125	0.00126	CcSEcCtD
Doxylamine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00124	0.00126	CcSEcCtD
Doxylamine—Somnolence—Conjugated Estrogens—osteoporosis	0.00124	0.00125	CcSEcCtD
Doxylamine—Constipation—Zoledronate—osteoporosis	0.00124	0.00125	CcSEcCtD
Doxylamine—Nausea—Alendronate—osteoporosis	0.00124	0.00125	CcSEcCtD
Doxylamine—Malaise—Estradiol—osteoporosis	0.00123	0.00125	CcSEcCtD
Doxylamine—Hypersensitivity—Risedronate—osteoporosis	0.00123	0.00124	CcSEcCtD
Doxylamine—Vertigo—Estradiol—osteoporosis	0.00123	0.00124	CcSEcCtD
Doxylamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00123	0.00124	CcSEcCtD
Doxylamine—Nausea—Raloxifene—osteoporosis	0.00121	0.00123	CcSEcCtD
Doxylamine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00121	0.00123	CcSEcCtD
Doxylamine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00121	0.00122	CcSEcCtD
Doxylamine—Palpitations—Estradiol—osteoporosis	0.00121	0.00122	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.0012	0.00122	CcSEcCtD
Doxylamine—Fatigue—Conjugated Estrogens—osteoporosis	0.0012	0.00122	CcSEcCtD
Doxylamine—Nausea—Ibandronate—osteoporosis	0.0012	0.00122	CcSEcCtD
Doxylamine—Asthenia—Risedronate—osteoporosis	0.0012	0.00121	CcSEcCtD
Doxylamine—Feeling abnormal—Zoledronate—osteoporosis	0.00119	0.00121	CcSEcCtD
Doxylamine—Constipation—Conjugated Estrogens—osteoporosis	0.00119	0.00121	CcSEcCtD
Doxylamine—Tamoxifen—ESR1—osteoporosis	0.00118	0.11	CrCbGaD
Doxylamine—Pruritus—Risedronate—osteoporosis	0.00118	0.00119	CcSEcCtD
Doxylamine—Nausea—Calcitriol—osteoporosis	0.00118	0.00119	CcSEcCtD
Doxylamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00117	0.00118	CcSEcCtD
Doxylamine—Hypersensitivity—Pamidronate—osteoporosis	0.00117	0.00118	CcSEcCtD
Doxylamine—Anxiety—Estradiol—osteoporosis	0.00116	0.00117	CcSEcCtD
Doxylamine—Urticaria—Zoledronate—osteoporosis	0.00115	0.00116	CcSEcCtD
Doxylamine—Discomfort—Estradiol—osteoporosis	0.00115	0.00116	CcSEcCtD
Doxylamine—Diarrhoea—Risedronate—osteoporosis	0.00114	0.00115	CcSEcCtD
Doxylamine—Dry mouth—Estradiol—osteoporosis	0.00114	0.00115	CcSEcCtD
Doxylamine—Asthenia—Pamidronate—osteoporosis	0.00114	0.00115	CcSEcCtD
Doxylamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00113	0.00114	CcSEcCtD
Doxylamine—Confusional state—Estradiol—osteoporosis	0.00113	0.00114	CcSEcCtD
Doxylamine—Pruritus—Pamidronate—osteoporosis	0.00112	0.00113	CcSEcCtD
Doxylamine—Anaphylactic shock—Estradiol—osteoporosis	0.00112	0.00113	CcSEcCtD
Doxylamine—Urticaria—Conjugated Estrogens—osteoporosis	0.00111	0.00112	CcSEcCtD
Doxylamine—Dizziness—Risedronate—osteoporosis	0.0011	0.00112	CcSEcCtD
Doxylamine—Nervous system disorder—Estradiol—osteoporosis	0.00109	0.00111	CcSEcCtD
Doxylamine—Tachycardia—Estradiol—osteoporosis	0.00109	0.0011	CcSEcCtD
Doxylamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00109	0.0011	CcSEcCtD
Doxylamine—Diarrhoea—Pamidronate—osteoporosis	0.00109	0.0011	CcSEcCtD
Doxylamine—Hyperhidrosis—Estradiol—osteoporosis	0.00108	0.00109	CcSEcCtD
Doxylamine—Rash—Ethinyl Estradiol—osteoporosis	0.00108	0.00109	CcSEcCtD
Doxylamine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00108	0.00109	CcSEcCtD
Doxylamine—Hypersensitivity—Zoledronate—osteoporosis	0.00107	0.00108	CcSEcCtD
Doxylamine—Vomiting—Risedronate—osteoporosis	0.00106	0.00107	CcSEcCtD
Doxylamine—Rash—Risedronate—osteoporosis	0.00105	0.00106	CcSEcCtD
Doxylamine—Dermatitis—Risedronate—osteoporosis	0.00105	0.00106	CcSEcCtD
Doxylamine—Dizziness—Pamidronate—osteoporosis	0.00105	0.00106	CcSEcCtD
Doxylamine—Asthenia—Zoledronate—osteoporosis	0.00104	0.00105	CcSEcCtD
Doxylamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00103	0.00104	CcSEcCtD
Doxylamine—Pruritus—Zoledronate—osteoporosis	0.00102	0.00104	CcSEcCtD
Doxylamine—Nausea—Ethinyl Estradiol—osteoporosis	0.00102	0.00103	CcSEcCtD
Doxylamine—Insomnia—Estradiol—osteoporosis	0.00101	0.00102	CcSEcCtD
Doxylamine—Vomiting—Pamidronate—osteoporosis	0.00101	0.00102	CcSEcCtD
Doxylamine—Asthenia—Conjugated Estrogens—osteoporosis	0.001	0.00101	CcSEcCtD
Doxylamine—Rash—Pamidronate—osteoporosis	0.001	0.00101	CcSEcCtD
Doxylamine—Dermatitis—Pamidronate—osteoporosis	0.000999	0.00101	CcSEcCtD
Doxylamine—Dyspnoea—Estradiol—osteoporosis	0.000995	0.00101	CcSEcCtD
Doxylamine—Somnolence—Estradiol—osteoporosis	0.000993	0.001	CcSEcCtD
Doxylamine—Diarrhoea—Zoledronate—osteoporosis	0.000991	0.001	CcSEcCtD
Doxylamine—Nausea—Risedronate—osteoporosis	0.000991	0.001	CcSEcCtD
Doxylamine—Pruritus—Conjugated Estrogens—osteoporosis	0.000987	0.000998	CcSEcCtD
Doxylamine—Decreased appetite—Estradiol—osteoporosis	0.000971	0.000981	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000964	0.000974	CcSEcCtD
Doxylamine—Fatigue—Estradiol—osteoporosis	0.000963	0.000973	CcSEcCtD
Doxylamine—Dizziness—Zoledronate—osteoporosis	0.000958	0.000968	CcSEcCtD
Doxylamine—Constipation—Estradiol—osteoporosis	0.000955	0.000965	CcSEcCtD
Doxylamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000954	0.000965	CcSEcCtD
Doxylamine—Nausea—Pamidronate—osteoporosis	0.000942	0.000952	CcSEcCtD
Doxylamine—Dizziness—Conjugated Estrogens—osteoporosis	0.000922	0.000933	CcSEcCtD
Doxylamine—Vomiting—Zoledronate—osteoporosis	0.000921	0.000931	CcSEcCtD
Doxylamine—Feeling abnormal—Estradiol—osteoporosis	0.00092	0.00093	CcSEcCtD
Doxylamine—Rash—Zoledronate—osteoporosis	0.000913	0.000923	CcSEcCtD
Doxylamine—Dermatitis—Zoledronate—osteoporosis	0.000913	0.000923	CcSEcCtD
Doxylamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000887	0.000897	CcSEcCtD
Doxylamine—Urticaria—Estradiol—osteoporosis	0.000887	0.000897	CcSEcCtD
Doxylamine—Rash—Conjugated Estrogens—osteoporosis	0.00088	0.000889	CcSEcCtD
Doxylamine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000879	0.000888	CcSEcCtD
Doxylamine—Nausea—Zoledronate—osteoporosis	0.000861	0.00087	CcSEcCtD
Doxylamine—Nausea—Conjugated Estrogens—osteoporosis	0.000829	0.000838	CcSEcCtD
Doxylamine—Hypersensitivity—Estradiol—osteoporosis	0.000823	0.000832	CcSEcCtD
Doxylamine—Asthenia—Estradiol—osteoporosis	0.000801	0.00081	CcSEcCtD
Doxylamine—Pruritus—Estradiol—osteoporosis	0.00079	0.000799	CcSEcCtD
Doxylamine—Diarrhoea—Estradiol—osteoporosis	0.000764	0.000772	CcSEcCtD
Doxylamine—Dizziness—Estradiol—osteoporosis	0.000738	0.000746	CcSEcCtD
Doxylamine—Vomiting—Estradiol—osteoporosis	0.00071	0.000718	CcSEcCtD
Doxylamine—Rash—Estradiol—osteoporosis	0.000704	0.000712	CcSEcCtD
Doxylamine—Dermatitis—Estradiol—osteoporosis	0.000703	0.000711	CcSEcCtD
Doxylamine—Nausea—Estradiol—osteoporosis	0.000663	0.00067	CcSEcCtD
